These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2497686)

  • 21. A summary of the current position of TRH in ALS therapy.
    Brooks BR
    Ann N Y Acad Sci; 1989; 553():431-61. PubMed ID: 2497685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathecal thyrotropin-releasing hormone in amyotrophic lateral sclerosis.
    Munsat TL; Taft J; Kasdon D
    Neurol Clin; 1987 Feb; 5(1):159-70. PubMed ID: 3104751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is thyrotropin releasing hormone an endogenous ergotropic substance in the brain?
    Metcalf G; Dettmar PW
    Lancet; 1981 Mar; 1(8220 Pt 1):586-9. PubMed ID: 6110823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term stability of single motor unit recordings in motor neuron disease: a macro EMG study.
    Guiloff RJ; Modarres-Sadeghi H; Stålberg E; Rogers H
    J Neurol Neurosurg Psychiatry; 1988 May; 51(5):671-6. PubMed ID: 3136230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM; Taft JA; Reichlin S; Munsat TL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of thyroliberin treatment on the thyrotropin and prolactin levels in patients with amyotrophic lateral sclerosis].
    Klimek A; Szulc-Kuberska J; Stepień H
    Neurol Neurochir Pol; 1990; 24(1-2):31-6. PubMed ID: 2132051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary effects of thyrotropin-releasing hormone in amyotrophic lateral sclerosis.
    Braun SR; Sufit RL; Brooks BR
    Lancet; 1984 Sep; 2(8401):529-30. PubMed ID: 6147597
    [No Abstract]   [Full Text] [Related]  

  • 28. [Trial of thyrotropin-releasing factor in amyotrophic lateral sclerosis].
    Serratrice G; Desnuelle C; Guelton C; Meyer-Dutour A; Richard P; Braguer D; Crevat A
    Presse Med; 1985 Feb; 14(8):487-8. PubMed ID: 3157152
    [No Abstract]   [Full Text] [Related]  

  • 29. Amyotrophic lateral sclerosis: a double-blind crossover trial of thyrotropin-releasing hormone.
    Imoto K; Saida K; Iwamura K; Saida T; Nishitani H
    J Neurol Neurosurg Psychiatry; 1984 Dec; 47(12):1332-4. PubMed ID: 6439824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical, electrophysiologic and endocrine effects of the perfusion of high doses of TRH in amyotrophic lateral sclerosis].
    Gueguen B; Puymirat J; Grouselle D; Piketty ML; Bleton JP; Bourdel MC; Rondot P
    Rev Neurol (Paris); 1988; 144(11):704-9. PubMed ID: 3148186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyrotrophin-releasing hormone. New applications in the clinic.
    Griffiths EC
    Nature; 1986 Jul 17-23; 322(6076):212-3. PubMed ID: 3090448
    [No Abstract]   [Full Text] [Related]  

  • 32. The therapeutic potential of thyrotropin releasing hormone (TRH) in Alzheimer's disease (AD).
    Yarbrough GG; Pomara N
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(3):285-9. PubMed ID: 3929331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protirelin (thyrotropin-releasing hormone) in amyotrophic lateral sclerosis. The role of androgens.
    Miller SC; Warnick JE
    Arch Neurol; 1989 Mar; 46(3):330-5. PubMed ID: 2563937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of motor neuron diseases using intrathecal TRH. Pilot study I].
    Patrignani Ochoa J; Morales Martínez D; Martínez Parra C
    Neurologia; 1988; 3(6):221-5. PubMed ID: 3152558
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of TRH analogues in motorneurone disease.
    Guiloff RJ
    Ann N Y Acad Sci; 1989; 553():399-421. PubMed ID: 2497683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyrotropin-releasing hormone in ALS. Are the results of clinical studies inconsistent?
    Brooke MH
    Ann N Y Acad Sci; 1989; 553():422-30. PubMed ID: 2497684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis.
    Chiodini PG; Attanasio R; Liuzzi A; Cozzi R; Orlandi P; De Palo C; Dallabonzana D; Girotti F; Testa D
    J Endocrinol Invest; 1990 Sep; 13(8):631-6. PubMed ID: 2125610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural functions of TRH.
    Reichlin S
    Acta Endocrinol Suppl (Copenh); 1986; 276():21-33. PubMed ID: 3019059
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone.
    Engel WK; Siddique T; Nicoloff JT
    Lancet; 1983 Jul; 2(8341):73-5. PubMed ID: 6134961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged intrathecal infusion of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
    Munsat TL; Taft J; Kasdon D; Jackson IM
    Ann N Y Acad Sci; 1988; 531():187-93. PubMed ID: 3132882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.